Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00105443
What this trial is testing

A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 602
Early research (Phase 1)Study completedNCT00441376
What this trial is testing

ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

Who this might be right for
Hepatocellular CarcinomaLiver Neoplasms
Imunon 30
Early research (Phase 1)Looking for participantsNCT06600321
What this trial is testing

Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
Alnylam Pharmaceuticals 158
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Not applicableLooking for participantsNCT05705219
What this trial is testing

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

Who this might be right for
Liver Cancer, Adult
University of California, San Diego 80
Early research (Phase 1)Looking for participantsNCT06533332
What this trial is testing

Trial of ERX-315 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more
EtiraRx Australia Pty Ltd 36
Not applicableStudy completedNCT04161911
What this trial is testing

Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 1,426
Not applicableNot Yet RecruitingNCT06977399
What this trial is testing

The Application Value of Spectral CT in the Accurate Staging of Liver Cancer

Who this might be right for
Liver Cancer
Yunnan Cancer Hospital 150
Testing effectiveness (Phase 2)UnknownNCT06413017
What this trial is testing

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Who this might be right for
HCC
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT00568308
What this trial is testing

Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma

Who this might be right for
CancerLiver CancerPrimary Liver Cancer+2 more
Progen Pharmaceuticals 600
Testing effectiveness (Phase 2)Study completedNCT00183885
What this trial is testing

A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
University of Southern California 76
Not applicableStudy completedNCT06384417
What this trial is testing

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

Who this might be right for
Breast CancerLung CancerGenito-Urinary Cancer+6 more
Milton S. Hershey Medical Center 30
Early research (Phase 1)Looking for participantsNCT05155189
What this trial is testing

Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 72
Not applicableLooking for participantsNCT06778317
What this trial is testing

MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)CirrhosisRisk Prediction for Liver Cancer+1 more
Central Hospital, Nancy, France 400
Not applicableUnknownNCT05443217
What this trial is testing

Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments

Who this might be right for
Liver CancerMicrobiotaAdverse Event+2 more
First Affiliated Hospital of Wenzhou Medical University 200
Not applicableEnded earlyNCT03753789
What this trial is testing

Ablation Confirmation Study

Who this might be right for
Cancer of the LiverLiver CancerNeoplasms, Liver
Ethicon, Inc. 46
Large-scale testing (Phase 3)Study completedNCT01908426
What this trial is testing

Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Exelixis 707
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05171335
What this trial is testing

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
The Methodist Hospital Research Institute 50
Early research (Phase 1)Study completedNCT00746317
What this trial is testing

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Advanced or Metastatic HCC
Chugai Pharmaceutical 27
Testing effectiveness (Phase 2)Study completedNCT02425735
What this trial is testing

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

Who this might be right for
Liver Cancer
Fuda Cancer Hospital, Guangzhou 40
Next Page